You just read:

Medicxi Ventures, Formerly Index Ventures Life Sciences, Launches as an Independent Venture Capital Firm and Announces Closing of a €210m Fund including GSK and Johnson & Johnson Innovation

News provided by

Medicxi Ventures

02 Feb, 2016, 06:00 GMT